NCT05388422

Application of 3D Scanner to Measure Physical Size in Patients With Severe Cerebral Palsy

Completed NA Last updated 1 May 2023

What this trial tests

NA trial testing Application of 3D scanner to measure physical size in patients with severe cerebral palsy in Cerebral Palsy, Spastic in 19 participants. Completed in 31 March 2023.

Timeline

2 June 2022

Primary endpoint
31 January 2023

31 March 2023

Quick facts

Lead sponsor	Seoul National University Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	19
Start date	2 June 2022
Primary completion	31 January 2023
Estimated completion	31 March 2023
Sites	1 location across South Korea

Drugs / interventions tested

• Application of 3D scanner to measure physical size in patients with severe cerebral palsy

Conditions studied

• Cerebral Palsy, Spastic — all drugs for Cerebral Palsy, Spastic →

Sponsor

Seoul National University Hospital

Who can join

Adults 1 to 15, any sex, with Cerebral Palsy, Spastic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to improve the manufacturing techniques of hip brace in preventing progressive hip displacement in patients with severe cerebral palsy, through the measurement of patient's physical size using a 3D scanner.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Application of 3D scanner to measure physical size and improvement of hip brace manufacturing technology in severe cerebral palsy patients.
   Kim JM, Lim J, Choi SY, Rhim SH, et al · · 2023 · PMID 38001232 · DOI 10.1038/s41598-023-47665-w